From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research

At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed how monoclonal antibodies transformed lymphoma treatment; Michel C. Nussenzweig, MD, PhD, of The Rockefeller University, explored affinity and diversity in the antibody response; and conference chair Michael Green, PhD, of The University of Texas MD Anderson Cancer Center, examined epigenetic mechanisms that affect response to targeted therapy.

The post From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research appeared first on American Association for Cancer Research (AACR).

Source: Oncology

Read More